1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA: A Cancer Journal for Clinicians 50:7–33, 2000.
2. Green, RA, Humprey, E, Close, H, et al. Alkylating agents in bronchogenic carcinoma. Am J Med 49:360–367, 1969.
3. Hirsch, FR, Matthews, MJ, Aisner, S, et al. Histopathologic classification of small cell lung cancer: Changing concepts and terminology. Cancer 62:973–977, 1988.
4. Hibi, K, Takahashi, T, Yamakawa, K, et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445–449, 1992.
5. Sozzi, G, Veroneses, ML, Negrini, M, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17–26, 1996.